Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women.

Chih-Wan LinK Arnold ChanYi-Yung ChenWei-I HuangPi-Hui ChaoHsun-Yin LiangWen-Wen ChenFei-Yuan Hsiao

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)

Pregnant women receiving intravenous ritodrine therapy had higher cardiopulmonary risks and should be intensively monitored. While the relative risk associated with oral ritodrine is not pronounced, it should be used judiciously among pregnant women as well.

Keyphrases

pregnant women
pregnancy outcomes
human health
genome wide
quality improvement
emergency department
adverse drug
low dose
mesenchymal stem cells
human immunodeficiency virus
climate change
cell therapy
hepatitis c virus
weight gain